Tradjenta (linagliptin) has been made available by Boehringer Ingelheim and Eli Lilly as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Tradjenta, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is available in a 5mg dosage strength tablet.

For more information call (800) 542-6257 or visit www.tradjenta.com.